Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Abbott Laboratories (ABT) P/B ratio

As of 25 September 2026, Abbott Laboratories (ABT) trades at a P/B ratio of 3.4×. Over the past ten years it has ranged from 2.3× (April 2017) to 7.2× (December 2021); the current reading is higher than 31% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 4.1× 0.60%
FY2024 4.1× (16.54%)
FY2023 4.9× (5.42%)
FY2022 5.2× (24.94%)
FY2021 6.9× 17.89%
FY2020 5.9× 19.89%
FY2019 4.9× 18.54%
FY2018 4.1× 25.83%
FY2017 3.3× 18.15%
FY2016 2.8× (11.63%)

Quarterly

Period P/B ratio Change
Jun 2026 3.1× (10.12%)
Mar 2026 3.4× (17.88%)
Dec 2025 4.1× (9.19%)
Sep 2025 4.6× (2.43%)
42 more quarters

Against its own ten years

Low 2.3× High 7.2×
Ten-year median 4.5×
Current reading's percentile 31

P/B ratio against peers

Company P/B ratio
PHG Koninklijke Philips N.V. compare 1.8×
MDT Medtronic PLC compare 2.2×
BSX Boston Scientific Corporation compare 2.6×
GEHC GE HealthCare Technologies Inc. compare 2.7×
STE STERIS plc compare 2.8×
ABT Abbott Laboratories 3.4×
SYK Stryker Corporation compare 4.4×
EW Edwards Lifesciences Corporation compare 4.6×
DXCM DexCom, Inc. compare 12.6×
Medical Devices industry median 2.5×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ABT